BL
Therapeutic Areas
Thunder Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MOTO-CAR Immunotherapy | Solid Tumors | Pre-clinical |
Leadership Team at Thunder Biotech
KO
Kim O'Neill, PhD
Founder & Chief Scientific Officer
KM
Kent Misener
Chairman of the Board of Directors